StonvexLoading…
StonvexStonvexStonvexCore line items from ADSK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-01-31 | Annual 2024 2024-01-31 | Annual 2023 2023-01-31 |
|---|---|---|---|---|
Revenue | $7.21B | $6.13B | $5.50B | $5.00B |
Operating Income | $1.58B | $1.35B | $1.13B | $989.00M |
Net Income | $1.12B | $1.11B | $906.00M | $823.00M |
EPS (Diluted) | $5.23 | $5.12 | $4.19 | $3.78 |
Total Assets | $12.47B | $10.83B | $9.91B | $9.44B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $2.25B | $1.60B | $1.89B | $1.95B |
Free Cash Flow OCF − CapEx | $2.41B | $1.57B | $1.28B | $2.03B |
Shares Outstanding | 212.00M | 214.00M | 214.00M | 215.00M |